A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

被引:417
作者
Hampel, Heather [1 ]
Bennett, Robin L. [2 ]
Buchanan, Adam [3 ]
Pearlman, Rachel [1 ]
Wiesner, Georgia L. [4 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA
[2] Univ Washington, Med Ctr, Dept Med, Genet Med Clin, Seattle, WA 98195 USA
[3] Duke Univ, Canc Prevent Detect & Control Res Program, Duke Canc Inst, Durham, NC USA
[4] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Clin & Translat Hereditary Canc Program, Div Med Genet,Dept Med, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
cancer genetics; cancer predisposition; genetic counseling; referral guidelines; referral indications; NONPOLYPOSIS COLORECTAL-CANCER; FAMILIAL PANCREATIC-CANCER; ENDOCRINE NEOPLASIA TYPE-2; ENDOLYMPHATIC SAC TUMORS; MIXED POLYPOSIS SYNDROME; LI-FRAUMENI-SYNDROME; FUMARATE HYDRATASE MUTATIONS; RET PROTOONCOGENE MUTATIONS; MEDULLARY-THYROID CARCINOMA; TUBEROUS SCLEROSIS COMPLEX;
D O I
10.1038/gim.2014.147
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Cancer genetic consultation is an important aspect of the care of individuals at increased risk of a hereditary cancer :syndrome. Yet several patient, clinician, and system-level barriers hinder identification of individuals appropriate for cancer genetics referral. Thus, the purpose of this practice guideline is to present a single set of comprehensive personal and family history criteria to facilitate identification and maximize appropriate referral of at-risk individuals for cancer genetic consultation. To develop this guideline, a literature search for hereditary cancer susceptibility syndromes was conducted using PubMed. In addition, GeneReviews and the National Comprehensive Cancer Network guidelines were reviewed when applicable. When conflicting guidelines were identified, the evidence was ranked as follows: position papers from national and professional organizations ranked highest, followed by consortium guidelines, and then peer-reviewed publications from single institutions. The criteria for cancer genetic consultation referral are provided in two formats: (i) tables that list the tumor type along with the criteria that, if met, would warrant a referral for a cancer genetic consultation and (ii) an alphabetical list of the syndromes, including a brief summary of each and the rationale for the referral criteria that were selected. Consider referral for a cancer genetic consultation if your patient or any of their first-degree relatives meet any of these referral criteria.
引用
收藏
页码:70 / 87
页数:18
相关论文
共 187 条
[1]
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[3]
2-C
[4]
Family history-taking in community family practice: Implications for genetic screening [J].
Acheson, LS ;
Wiesner, GL ;
Zyzanski, SJ ;
Goodwin, MA ;
Stange, KC .
GENETICS IN MEDICINE, 2000, 2 (03) :180-185
[5]
Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer [J].
Alam, NA ;
Olpin, S ;
Leigh, IM .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) :11-17
[6]
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency [J].
Alam, NA ;
Rowan, AJ ;
Wortham, NC ;
Pollard, PJ ;
Mitchell, M ;
Tyrer, JP ;
Barclay, E ;
Calonje, E ;
Manek, S ;
Adams, SJ ;
Bowers, PW ;
Burrows, NP ;
Charles-Holmes, R ;
Cook, LJ ;
Daly, BM ;
Ford, GP ;
Fuller, LC ;
Hadfield-Jones, SE ;
Hardwick, N ;
Highet, AS ;
Keefe, M ;
MacDonald-Hull, SP ;
Potts, EDA ;
Crone, M ;
Wilkinson, S ;
Camacho-Martinez, F ;
Jablonska, S ;
Ratnavel, R ;
MacDonald, A ;
Mann, RJ ;
Grice, K ;
Guillet, G ;
Lewis-Jones, MS ;
McGrath, H ;
Seukeran, DC ;
Morrison, PJ ;
Fleming, S ;
Rahman, S ;
Kelsell, D ;
Leigh, I ;
Olpin, S ;
Tomlinson, IPM .
HUMAN MOLECULAR GENETICS, 2003, 12 (11) :1241-1252
[7]
Genetic testing in pheochromocytoma or functional paraganglioma [J].
Amar, L ;
Bertherat, J ;
Baudin, E ;
Ajzenberg, C ;
Bressac-de Paillerets, B ;
Chabre, O ;
Chamontin, B ;
Delemer, B ;
Giraud, S ;
Murat, A ;
Niccoli-Sire, P ;
Richard, SP ;
Rohmer, V ;
Sadoul, JL ;
Strompf, L ;
Schlumberger, M ;
Bertagna, X ;
Plouin, PF ;
Jeunemaitre, X ;
Gimenez-Roqueplo, AP .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8812-8818
[8]
[Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4
[10]
High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome [J].
Aretz, S. ;
Stienen, D. ;
Uhlhaas, S. ;
Stolte, M. ;
Entius, M. M. ;
Loff, S. ;
Back, W. ;
Kaufmann, A. ;
Keller, K-M ;
Blaas, S. H. ;
Siebert, R. ;
Vogt, S. ;
Spranger, S. ;
Holinski-Feder, E. ;
Sunde, L. ;
Propping, P. ;
Friedl, W. .
JOURNAL OF MEDICAL GENETICS, 2007, 44 (11) :702-709